Drug Profile
DOB 0041
Latest Information Update: 20 Jun 2000
Price :
$50
*
At a glance
- Originator Dompe
- Class Anti-inflammatories
- Mechanism of Action Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 20 Jun 2000 Discontinued-Preclinical for Inflammation in Italy (Unknown route)
- 22 Sep 1997 New profile
- 22 Sep 1997 Preclinical development for Inflammation in Italy (Unknown route)